TY - JOUR
T1 - Presenting features in 269 patients with clinically nonfunctioning pituitary adenomas enrolled in a prospective study
AU - Freda, Pamela U.
AU - Bruce, Jeffrey N.
AU - Khandji, Alexander G.
AU - Jin, Zhezhen
AU - Hickman, Richard A.
AU - Frey, Emily
AU - Reyes-Vidal, Carlos
AU - Otten, Marc
AU - Wardlaw, Sharon L.
AU - Post, Kalmon D.
N1 - Publisher Copyright:
© 2020 Endocrine Society.
PY - 2020
Y1 - 2020
N2 - Context: Clinically nonfunctioning pituitary adenomas (CNFPAs) typically remain undetected until mass effect symptoms develop. However, currently, head imaging is performed commonly for many other indications, which may increase incidental discovery of CNFPAs. Since current presentation and outcome data are based on older, retrospective series, a prospective characterization of a contemporary CNFPA cohort was needed. Objective: To determine the prevalence of incidental presentation and hypopituitarism and its predictors in a CNFPA cohort that spanned 6 to 9 mm micro-to macroadenoma included observational and surgical therapy. Methods: At enrollment in a prospective, observational study, 269 patients with CNFPAs were studied by history, examination, blood sampling, and pituitary imaging analysis and categorized into incidental or symptoms presentation groups that were compared. Results: Presentation was incidental in 48.7% of patients and due to tumor symptoms in 51.3%. In the symptoms and incidental groups, 58.7% and 27.4% of patients had hypopituitarism, respectively, and 25% of patients with microadenomas had hypopituitarism. Many had unappreciated signs and symptoms of pituitary disease. Most tumors were macroadenomas (87%) and were larger in the symptoms than incidental and hypopituitary groups than in the eupituitary groups. The patients in the incidental group were older, and males were older and had larger tumors in both the incidental and symptoms groups. Conclusions: Patients with CNFPAs commonly present incidentally and with previously unrecognized hypopituitarism and symptoms that could have prompted earlier diagnosis. Our data support screening all large micro and macro-CNFPAs for hypopituitarism. Most patients with CNFPAs still have mass effect signs at presentation, suggesting the need for more awareness of pituitary disease. Our ongoing, prospective observation of this cohort will assess outcomes of these CNFPA groups. the original work is not altered or transformed in any way, and that the work is properly cited.
AB - Context: Clinically nonfunctioning pituitary adenomas (CNFPAs) typically remain undetected until mass effect symptoms develop. However, currently, head imaging is performed commonly for many other indications, which may increase incidental discovery of CNFPAs. Since current presentation and outcome data are based on older, retrospective series, a prospective characterization of a contemporary CNFPA cohort was needed. Objective: To determine the prevalence of incidental presentation and hypopituitarism and its predictors in a CNFPA cohort that spanned 6 to 9 mm micro-to macroadenoma included observational and surgical therapy. Methods: At enrollment in a prospective, observational study, 269 patients with CNFPAs were studied by history, examination, blood sampling, and pituitary imaging analysis and categorized into incidental or symptoms presentation groups that were compared. Results: Presentation was incidental in 48.7% of patients and due to tumor symptoms in 51.3%. In the symptoms and incidental groups, 58.7% and 27.4% of patients had hypopituitarism, respectively, and 25% of patients with microadenomas had hypopituitarism. Many had unappreciated signs and symptoms of pituitary disease. Most tumors were macroadenomas (87%) and were larger in the symptoms than incidental and hypopituitary groups than in the eupituitary groups. The patients in the incidental group were older, and males were older and had larger tumors in both the incidental and symptoms groups. Conclusions: Patients with CNFPAs commonly present incidentally and with previously unrecognized hypopituitarism and symptoms that could have prompted earlier diagnosis. Our data support screening all large micro and macro-CNFPAs for hypopituitarism. Most patients with CNFPAs still have mass effect signs at presentation, suggesting the need for more awareness of pituitary disease. Our ongoing, prospective observation of this cohort will assess outcomes of these CNFPA groups. the original work is not altered or transformed in any way, and that the work is properly cited.
KW - Hypopituitarism
KW - Incidentaloma
KW - Pituitary tumor
UR - http://www.scopus.com/inward/record.url?scp=85089945483&partnerID=8YFLogxK
U2 - 10.1210/JENDSO/BVAA021
DO - 10.1210/JENDSO/BVAA021
M3 - Article
AN - SCOPUS:85089945483
SN - 2472-1972
VL - 4
SP - 1
EP - 13
JO - Journal of the Endocrine Society
JF - Journal of the Endocrine Society
IS - 4
ER -